• Source: Telapristone

Telapristone (INNTooltip International Nonproprietary Name), as telapristone acetate (proposed brand names Proellex, Progenta; former code name CDB-4124), is a synthetic, steroidal selective progesterone receptor modulator (SPRM) related to mifepristone which is under development by Repros Therapeutics for the treatment of breast cancer, endometriosis, and uterine fibroids. It was originally developed by the National Institutes of Health (NIH), and, as of 2017, is in phase II clinical trials for the aforementioned indications. In addition to its activity as an SPRM, the drug also has some antiglucocorticoid activity.




See also


List of investigational sex-hormonal agents § Progestogenics
Aglepristone
Lilopristone
Onapristone
Toripristone




References






External links


Telapristone - AdisInsight

Kata Kunci Pencarian:

• Telapristone
• Selective progesterone receptor modulator
• Steroid
• Spironolactone
• Betamethasone
• Prednisone
• Dexamethasone
• Triamcinolone acetonide
• Glucocorticoid
• Trenbolone